Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li>Krsnaa Diagnostics is likely to announce its share allotment status for its IPO on Wednesday.</li><li>The public issue was oversubscribed by 64.40 times on the third and last day of listing.</li><li>The company received bids for 45.80 crore shares as against 71.12 lakh shares on offer.</li><li>Check out the latest news and updates on <a href="https://www.businessinsider.in/">Business Insider</a>.</li></ul>Krsnaa Diagnostics is likely to announce its share allotment status for its initial public offering (IPO) on Wednesday, August 11. Krsnaa Diagnostics offers a wide range of diagnostic services such as imaging, pathology or clinical laboratory and tele-radiology services to public and private hospitals, medical colleges and community health centres across India. The company is looking to raise ₹1,213 crore at the higher end of the price band of ₹933-954 per share. It will use the proceeds to aid its expansion plans and set up new diagnostics centres in different parts of the country — Punjab, Karnataka, Himachal Pradesh and Maharashtra. A part of the proceeds would also be used for repayment and prepayment of loans. The issue opened for bidding on August 4 to August 6, and it was oversubscribed by 64.40 times. The company received bids for 45.80 crore shares as against 71.12 lakh shares on offer. Here is how to check Krsnaa Diagnostics’ IPO allotment status on stock exchange website: <ul><li>Go to the <a href="https://www.bseindia.com/investors/appli_check.aspx">BSE website</a> or NSE website<a href="https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp"> here</a>.</li><li>On BSE, Select 'Equity' and then from the dropdown, select 'Krsnaa Diagnostics’.</li><li>Now, enter your application number and PAN.</li><li>Click on 'Search'.</li><li>Please note the details will only be available once the shares are allotted.</li></ul>You can also visit the registrar website (Link Intime India) to check your application <ul><li>Visit the registrar's website <a href="https://linkintime.co.in/MIPO/Ipoallotment.html">here</a>.</li><li>Click on 'Select company' and click on ‘Krsnaa Diagnostics’.</li><li>Once the company is selected, you will have to enter either your PAN detail, the application number, or the client ID.</li><li>Enter the captcha and click ’submit’.</li></ul>Once you hit 'submit', the status of your application will appear on the screen. Please ensure the details that you provide are correct. It will show the number of shares you subscribed to and the number of shares allotted to you. SEE ALSO <a href="https://www.businessinsider.in/business/startups/news/oyo-takes-first-step-towards-a-1-2-billion-ipo/articleshow/85176310.cms">OYO takes first step towards a $1.2 billion IPO, reportedly appoints 3 investment banks</a> <a href="https://www.businessinsider.in/business/startups/news/investment-firm-iron-pillar-is-planning-to-bring-assets-worth-1-billion-under-management-aum/articleshow/85161486.cms">FreshtoHome and BlueStone-backer Iron Pillar is planning to bring assets worth $1 billion under management</a> <a href="https://www.businessinsider.in/business/telecom/news/vodafone-idea-and-airtel-shares-fall-as-sc-rejects-agr-dues-re-computation-appeal/articleshow/84668288.cms">Vodafone Idea sinks nearly 10% and Airtel tumbles a bit after India’s Supreme Court denies a discount on past dues</a>

Krsnaa Diagnostics IPO: How to check your allotment status

<ul><li><keyword id="11949917" type="General" weightage="20" keywordseo="vijaya-diagnostic-ipo" source="Orion">Vijaya Diagnostic IPO</keyword> opened on September 1 and closes today, September 3, is the last day of its subscription.</li><li>So far, in the last two days of issue, it has received a tepid response from investors.</li><li>Meanwhile, analysts advise investors to subscribe to the IPO because of the company’s strong footing in south India and that it is cash rich and does not require any further capital for growth.</li></ul>If you are looking to invest in the initial public offering (IPO) of Vijaya Diagnostic, then go ahead as today, September 3, is the last day of the issue. The IPO application is live from 10 a.m. to 5 p.m. So far, in the first two days of subscription, the IPO has received a tepid response from all categories of retail investors. The portion reserved for retail investors was subscribed 0.74 times the issue size on the second day of the issue i.e. September 2. Overall, the issue was subscribed 0.47 times on the second day. The IPO has received bids for 1.18 crore equity shares against the IPO size of 2.50 crore equity shares. The IPO for Vijaya Diagnostic opened Wednesday, September 1 and will close on September 3, with a price band of ₹522-531. Further, analysts advise investors to subscribe to the IPO given the chain’s strong footing in south India. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Broking house </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Recommendation </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Ventura </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Nirmal Bang </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe for long term </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">ICICI Direct </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Unrated </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Angel Broking </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Neutral </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Reliance Securities </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IIFL Securities </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Hem Securities </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr></tbody></table> “The company is cash rich and does not require any further capital for growth,” said Ventura Securities while recommending to ‘subscribe’ to the IPO for long-term investing with a price target of ₹672, indicating an upside of 27% over the next 24 months. However, the grey market premium for Vijaya Diagnostic IPO is not very exciting. The firm has ₹250 crore cash on its books, Sunil Chandra Kondapally, executive director at Vijaya Diagnostic, <a href="https://www.businessinsider.in/stock-market/news/ipo-bound-vijaya-diagnostics-is-planning-more-acquisitions-in-east-india/articleshow/85755911.cms">told Business Insider</a>. Analysts at Ventura Capital recommend subscribing to the IPO for long-term investing with a price objective of ₹672, representing an upside of 27% over the next 24 months. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/triggers-that-stock-markets-are-ignoring-amid-record-high-euphoria/articleshow/85861684.cms">Sobering signals that Indian stock markets may be ignoring in this euphoria</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/telecom/news/vodafone-idea-shares-spike-after-promoter-kumar-mangalam-birlas-meeting-with-indias-telecom-minister/articleshow/85861279.cms">Vodafone Idea shares spike after promoter Kumar Mangalam Birla's meeting with India's Telecom minister</a>

Vijaya Diagnostic IPO’s last day to subscribe, grey market indicates ₹15-₹20 premium

<ul><li>The company is likely to announce its share allotment status on September 8.</li><li>The IPO of the diagnostics lab chain Vijaya Diagnostic was subscribed 4.54 times on the last day of bidding.</li><li>Investors have bid for 11.36 crore shares against the 2.50 crore shares on offer.</li></ul>Diagnostics lab chain Vijaya Diagnostic is likely to announce the allotment of its initial public offering (IPO) status on September 8. The IPO was open for subscription between September 1 and September 3. Vijaya Diagnostic is looking to raise ₹1,895 crore through an entire offer for sale (OFS) from existing promoters with 3.56 crore equity shares. The IPO has received good response from investors, especially from qualified institutional buyers and non-institutional investors. The portion for qualified institutional investors was subscribed 13.07 times while the non-institutional investor category received a bid for 1.32 times. Overall, the investors have bid for 11.36 crore shares against the 2.50 crore shares on offer. The company has a strong presence in southern India in the states of Andhra Pradesh and Telangana and now looks to expand in some eastern states primarily through acquisition. “We are a debt-free company and due to our strong margin we also have liquidity on the balance sheet. We have built up a ₹250 crore cash on the book so priority is to use that corpus for the growth of the business. So we are definitely open for acquisition opportunities in any markets of interest,” said Sunil Chandra Kondapally, executive director at Vijaya Diagnostic in an interview with Business Insider. Here is how to check <keyword id="12039977" type="General" weightage="20" keywordseo="vijaya-diagnostic-ipo-allotment" source="Orion">Vijaya Diagnostic IPO allotment</keyword> status on stock exchange website: <ul><li>Go to the <a href="https://www.bseindia.com/investors/appli_check.aspx">BSE website</a> or NSE website<a href="https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp"> here</a>.</li><li>On BSE, Select 'Equity' and then from the dropdown, select 'Vijaya Diagnostic.</li><li>Now, enter your application number and PAN.</li><li>Click on 'Search'.</li><li>Please note the details will only be available once the shares are allotted.</li></ul>You can also visit the registrar website (Link Intime India) to check your application status. <ul><li>Visit the registrar's website <a href="https://linkintime.co.in/MIPO/Ipoallotment.html">here</a>.</li><li>Click on 'Select company' and click on 'Vijaya Diagnostic’.</li><li>Once the company is selected, you will have to enter either your PAN detail, the application number, or the client ID.</li><li>Enter the captcha and click ’submit’.</li></ul>Once you hit 'submit', the status of your application will appear on the screen. Please ensure the details that you provide are correct. It will show the number of shares you subscribed to and the number of shares allotted to you. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/finance/banks/news/axis-bank-announces-new-policies-and-practices-for-its-customers/articleshow/85978495.cms">Axis Bank announces new policies and practices for its customers and employees belonging to the LGBTQ community</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/real-estate-company-stocks-become-multibaggers-while-analysts-see-further-strong-upside/articleshow/85976693.cms">Sobha, Mahindra Lifespace become multibaggers in 2021 as analysts see strong upside in realty space</a>

Here’s how to check Vijaya Diagnostic IPO allotment status, listing date and more

<ul><li><keyword id="11265920" type="UNKNOWN" weightage="20" keywordseo="Krsnaa-Diagnostics-IPO">Krsnaa Diagnostics IPO</keyword> opens on August 4 and closes on August 6.</li><li>Demat account, trading application and UPI ID are mandatory if you are applying for an initial public offering (IPO).</li><li>Krsnaa Diagnostics is looking to raise ₹1,213 crore at the upper price band of ₹ 954 per share.</li></ul>Another initial public offering (IPO) in line this week is of Krsnaa Diagnostics, one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology services to public and private hospitals, medical colleges and community health centres across India. It is looking to raise ₹1,213 crore at the higher end of the price band of ₹933-954 per share. Here is a guide on how to apply for IPOs easily. Firstly, to invest in an IPOs, you need to apply to buy a ‘lot of shares’ from the market. The bidding for these IPOs is usually open for three days particularly during market hours. For Krsnaa Diagnostics IPO the bidding will open on August 4 and close on August 6. A Demat account, a trading application like Zerodha, Angel Broking etc and UPI ID on BHIM app are necessary if you want to invest conveniently in an IPO. Unified payment interface (UPI) is a banking system for money transfers on payment apps like Google Pay, PhonePe and so on. One of the simplest ways to track IPOs and invest in them is through trading platforms. Here’s how you can do it through Zerodha’s Kite application, which is meant for trading stocks and commodities. <ul><li>Login to the mobile app and select the IPO option under the console. If you’re logging in through desktop, then go to console -- portfolio -- IPO.</li><li>You will find a list of IPOs that are open for investment. Select the IPO you want to invest in.</li><li>Enter your UPI ID from the BHIM app. Ensure your UPI ID is mapped to your personal bank account.</li><li>Enter the lot size (number of shares required to buy in one lot) announced by the company.</li><li>Tick on the cut off price for more chances of allotment of shares as it indicates investor’s willingness to subscribe to shares at any price discovered within the price band. Cut off price is the issue price.</li><li>Retail investors can bid for a maximum of three lots.</li><li>After this step, click on the check box to confirm and submit.</li><li>The last step is to accept the mandate request for proceeding with IPO on your BHIM UPI app. Once you accept the mandate, the amount of funds for IPO will be blocked till the allotment.</li><li>Now wait till the allotment date of shares to see if you have received the lot size you bid for.</li></ul>If you have invested through broking firm like Upstox, here are the 5 simple steps to invest in an IPO: Step 1: Login to the Upstox application or website with your credentials. Step 2: Select the IPO that you want to invest in and create an IPO application. Step 3: Add up to 3 bids within the price range. Step 4: Confirm your application. Step 5: Accept the UPI mandate and block funds on your mobile UPI app Another way to invest is through your bank. This option is generally available between 5 a.m. and 11 a.m. on the bank’s website. Here’s how to do it: <ul><li>Log in to your bank’s net banking account.</li><li>Go to the investment section and select the IPO option.</li><li>Fill your investment and bank account details to complete the verification process.</li><li>Later select the IPO you want to apply for.</li><li>Enter the number of shares and bid price.</li><li>Read and accept ‘terms and conditions’ documents.</li><li>Submit your application.</li></ul>SEE ALSO: <a href="https://www.businessinsider.in/business/corporates/news/adani-ports-shows-a-record-quarterly-volume-growth-while-the-shares-have-already-run-up-over-7-in-last-5-days/articleshow/85005554.cms">Adani Ports shows a record quarterly volume growth while the shares have already run up over 7% in last 5 days </a><a href="https://www.businessinsider.in/stock-market/news/heres-why-nifty-broke-the-16000-barrier/articleshow/85004061.cms">Here’s why Nifty broke the 16,000 barrier ⁠— Titan, HDFC, Nestle and Ultratech tell the story of the euphoria in the Indian stock market </a>

Krsnaa Diagnostics IPO opens—here is all you need to know

Watch out for 4 IPOs opening on August 4— here’s a snapshot for each of the companies selling shares tomorrow

<ul><li><keyword id="12447226" type="General" weightage="20" keywordseo="tarsons" source="Orion">Tarsons</keyword> Products has received bids for 3.88 crore equity shares versus the 1.08 crore shares up for sale.</li><li>The company intends to raise ₹1,023 crore through its public issue, which includes ₹150 crore as issue of new shares.</li><li>The company will use their capital to repay its debts and spend on the manufacturing facility at Panchla in West Bengal.</li></ul>The initial public offering (IPO) of Tarsons Products continued to witness good demand from investors across the board on the second day of its public issue. The company would be listed on the <a href="https://www.businessinsider.in/stock-market/news/tarson-products-ipo-opens-today-and-closes-on-november-17/articleshow/87709719.cms">stock exchange on November 25</a>. The grey market premium of Tarsons Products shares is <a href="https://www.livemint.com/market/ipo/tarsons-products-ipo-what-gmp-signals-on-second-day-of-subscription-11637035990127.html">reportedly</a> at ₹180. Tarsons Products — which is a labware supplier to the life sciences sector— has received bids for 3.88 crore equity shares versus the 1.08 crore shares that were up for sale. The retail portion has been oversubscribed by 4.74 times and the portion reserved for non-institutional investors has been subscribed 3.98 times. Qualified institutional buyers — which includes banks, mutual funds and others — have subscribed to the IPO 1.30 times. The issue has been subscribed by 3.6 times. Tarsons Products’ public issue will close today, November 17. Interest investors can place their bidding, within a range of ₹645-662 apiece. The lot size has been set at 22 shares,which means that the investors would have to spend at least ₹14,190 to subscribe to the shares. Tarsons Products is engaged in designing, developing, manufacturing and supplying a diverse range of quality labware products used in laboratories across research organisations, academic institutes, pharmaceutical firms, diagnostics companies and hospitals. It manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare. The company intends to raise ₹1,023 crore through its public issue, which comprises ₹ 150 crore as fresh issue. The remaining ₹873 crore will be raised through offer for sale (OfS) and will go to the investors selling their shares in the IPO. The company will use their capital to repay its debts and spend on the manufacturing facility at Panchla in West Bengal. SEE ALSO <a href="https://www.businessinsider.in/business/startups/news/former-myntra-ceo-started-mensa-brand-in-may-and-its-already-worth-a-billion-dollars-with/articleshow/87735832.cms" data-type="tilCustomLink" style="">Former Myntra CEO started Mensa Brand in May ⁠and it’s already worth a billion dollars</a> <a href="https://www.businessinsider.in/cryptocurrency/news/cryptocurrencies-tumble-as-china-continues-its-crackdown-against-mining/articleshow/87738496.cms" data-type="tilCustomLink" style="">Cryptocurrencies tumble as China continues its crackdown against mining</a> <a href="https://www.businessinsider.in/stock-market/news/reliance-industries-makes-for-nearly-third-of-niftys-fall-today-tata-motors-and-maruti-beat-the-trend/articleshow/87736157.cms" data-type="tilCustomLink" style="">Reliance Industries makes for nearly a third of Nifty’s fall today ⁠— Tata Motors and Maruti beat the trend</a>

Tarsons Products IPO — today is the last day to subscribe, GMP at ₹180

<ul><li>Tarsons Products is likely to announce its share allotment status today.</li><li>The grey market premium of the Indian labware company Tarsons Products has come down to ₹170 from ₹230 earlier.</li><li>The IPO of the company was subscribed 77.49 times on the last day of bidding.</li></ul>Indian labware company Tarsons Products is likely to announce the allotment status of its initial public offering (IPO) today, November 23. The IPO was open for subscription from November 15 to November 17. The company was looking to raise over ₹1,024 crore through the IPO of a fresh issue of equity shares worth ₹150 crore and an offer for sale (OFS) of 1.32 crore equity shares that will be sold by promoters and an investor <keyword id="12496770" type="General" weightage="20" keywordseo="tarsons-products-ipo" source="Orion">Tarsons Products IPO</keyword> received subscriptions for 77.49 times the number of shares offered in the three days of IPO bidding process. The grey market premium of the company’s shares show a premium of ₹170 from the higher end of the price band. The portion reserved for retail investors was oversubscribed by 10.56 times on the last day of the IPO bidding process. Tarsons Products is engaged in designing, developing, manufacturing and supplying a diverse range of quality labware products used in laboratories across research organisations, academic institutes, pharmaceutical firms, diagnostics companies and hospitals. Here is how to <keyword id="12587146" type="General" weightage="20" keywordseo="tarsons-products-ipo-allotment" source="Orion">Tarsons Products IPO allotment</keyword> status on stock exchange website: <ul><li>Go to the <a href="https://www.bseindia.com/investors/appli_check.aspx">BSE website</a> or NSE website<a href="https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp"> here</a>.</li><li>On BSE, Select 'Equity' and then from the dropdown, select ‘Tarsons Products’.</li><li>Now, enter your application number and PAN.</li><li>Click on 'Search'.</li><li>Please note the details will only be available once the shares are allotted.</li></ul>You can also visit the registrar website (Link Intime India) to check your application status. <ul><li>Visit the registrar's website <a href="https://linkintime.co.in/MIPO/Ipoallotment.html">here</a>.</li><li>Click on 'Select company' and click on ‘Tarsons Products’.</li><li>Once the company is selected, you will have to enter either your PAN detail, the application number, or the client ID.</li><li>Enter the captcha and click ’submit’.</li></ul>Once you hit 'submit', the status of your application will appear on the screen. Please ensure the details that you provide are correct. It will show the number of shares you subscribed to and the number of shares allotted to you. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/latent-view-ipo-may-list-on-a-positive-note-despite-a-weak-market/articleshow/87850476.cms">Latent View IPO that got bigger traction than Paras Defence may list on a positive note despite a weak market</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/paytm-ccd-reliance-power-have-had-the-worst-stock-market-debut/slidelist/87845689.cms">Paytm, Cafe Coffee Day and Reliance Power — here’s are the worst stock market debut ever</a>

Tarsons Products IPO: Here’s how you can check the allotment status

<ul><li><keyword id="12496770" type="General" weightage="20" keywordseo="tarsons-products-ipo" source="Orion">Tarsons Products IPO</keyword> is all set to list in stock exchanges tomorrow, November 26.</li><li>Investors have shown good interest in the IPO as it has been subscribed 77.49 times.</li><li>The grey market premium of the Indian labware company has come down to ₹170 from ₹200 earlier.</li></ul>Indian labware company Tarsons Products is all set to list its initial public offering (IPO) on stock exchanges tomorrow, November 26. The IPO has shown a good response from investors as it has been subscribed 77.49 times. While the company was looking to raise ₹1,024 crore through the IPO, it received bids for ₹55,625 crore. Investors have bid for 84 crore stocks out of 1.08 stock available for bids. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Investors </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Subscription status </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Qualified Institutional Investors </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">115.77 times </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Non-Institutional Investors </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">184.58 times </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Retail </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">10.56 times </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Overall </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">77.49 times </td></tr></tbody></table> However, the grey market premium of the Indian labware company has come down to ₹170 from ₹200 earlier. The IPO consisted of a fresh issue of equity shares worth ₹150 crore and an offer for sale (OFS) of 1.32 crore equity shares that will be sold by promoters and an investor. Some of the company’s clients include Dr Reddy's Laboratories, Metropolis Healthcare, Dr. Lal Path Labs. Tarsons sells nearly one in every ten labware products sold in India. Analysts are betting big on the healthcare sector even post covid and expect the labware products company to continue growing. “COVID has turned out to be a boon for the companies in the healthcare space as worldwide governments have started allocating more funds and people in general have become more conscious towards the healthcare benefits. We expect the firm to grow faster than current CAGR [compound annual growth rate] given the laboratory instrument industry is growing at 20%,” said analysts at Nirmal Bang. Tarsons Products is engaged in designing, developing, manufacturing and supplying a diverse range of quality labware products used in laboratories across research organisations, academic institutes, pharmaceutical firms, diagnostics companies and hospitals. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/how-to-check-go-fashions-ipo-allotment-status/articleshow/87891055.cms">Go Fashion IPO’s allotment status would be announced today, GMP at ₹425</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/reliance-industries-coal-india-and-other-top-stocks-to-watch-out-for-on-november-25/slidelist/87901109.cms">Reliance Industries, Coal India and other top stocks to watch out for on November 25</a>

Tarsons Products IPO listing tomorrow; GMP staggers around ₹170

<ul><li><keyword id="11101421" type="UNKNOWN" weightage="20" keywordseo="Chemplast-Sanmar-IPO">Chemplast Sanmar IPO</keyword> opens on Tuesday and concludes on August 12.</li><li>The speciality chemical manufacturer is looking to raise ₹3,850 crore through the public issue of shares.</li><li>It is one of the leading suppliers of intermediates for global agrochemical, pharmaceutical and fine chemical innovators.</li></ul>Amid several initial public offerings (IPOs) opening this week, one is of the speciality chemical manufacturer Chemplast Sanmar. The Chennai-based company is looking to raise ₹ 3,850 crore through the public issue of shares that is open for bidding on Tuesday and will close on August 12. The offer will comprise of ₹1,300 crore fresh issue and offer for sale (OFS) up to ₹2,550 crore from existing shareholders. Chemplast Sanmar is a speciality chemical manufacturer with a focus on speciality paste poly vinyl chloride (PVC) resin and custom manufacturing of starting materials and intermediates for pharmaceutical, agro-chemical and fine chemicals sectors. Here are some of the important dates you should remember. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Issue details </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;"> </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Price band </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹530-₹541 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO open date </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 10 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO close date </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 12 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Allotment date </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 18 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Initiation of refunds </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 20 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Credit of shares to demat account </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 23 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO listing date </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 24 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Minimum lot </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">27 </td></tr></tbody></table> The company also manufactures caustic soda, chlorochemicals, hydrogen peroxide, refrigerant gas and industrial salt. It has four manufacturing facilities, of which three are located in Tamil Nadu and one is located in Puducherry. SEE ALSO:<a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/aptus-value-housing-ipo-how-to-apply-for-this-ipo-via-banks-and-trading-apps/articleshow/85199189.cms">Aptus Value Housing IPO: Here is how you can easily apply for the issue that opens today</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/krsnaa-diagnostics-ipo-how-to-check-your-allotment-status/articleshow/85182483.cms">Krsnaa Diagnostics IPO: How to check your allotment status</a>

Chemplast Sanmar IPO opens today: Check issue price, allotment dates and key details here

<ul><li>Tarsons Products announced its share allotment status on Tuesday.</li><li>The grey market premium of the Indian labware company Tarsons Products is ₹160.</li><li>The IPO of the company was subscribed 77.49 times on the last day of bidding.</li></ul>The allotment status of Indian labware company Tarsons Products was announced on Tuesday and by now the investors, who unfortunately did not get the shares, should start getting their refunds. If you have not checked whether you received the initial public offering (IPO) allotment or not, <a href="https://www.businessinsider.in/stock-market/news/tarsons-products-ipo-heres-how-to-check-your-allotment-status/articleshow/87857321.cms">click here </a>and follow the procedure. All the investors who got the allotment will receive the shares in their demat account on the date of listing, which in this case is November 26. Usually every applicant gets a message on their registered phone number, highlighting whether the funds are blocked or unblocked. Blocked funds indicate that the shares have been transferred to the investor, whereas the unblocked fund means that the cash has been transferred back to the investor’s bank account. Investors receive a validity period while making the payments for the shares. The IPO amount is usually refunded one day later the IPO allotment or before the end of the validity period. <div type="image" title="If you missed Tarson Products’ IPO allotment, here’s what you should know" msid="87870784" hostid="261"></div> Tarsons Products opened its IPO on November 15 to November 17, at a price band of ₹635-₹662 per share. The IPO received subscriptions for 77.49 times the number of shares offered in the three days of IPO bidding process. The grey market premium of the company’s shares show a premium of ₹160 on November 23. The company has raised over ₹1,024 crore through the IPO of a fresh issue of equity shares worth ₹150 crore and an offer for sale (OFS) of 1.32 crore equity shares that will be sold by promoters and an investor. Tarsons Products is engaged in designing, developing, manufacturing and supplying a diverse range of quality labware products used in laboratories across research organisations, academic institutes, pharmaceutical firms, diagnostics companies and hospitals. SEE ALSO <a href="https://www.businessinsider.in/business/telecom/news/jio-is-slowing-down-in-the-race-to-500-million-subscribers/articleshow/87862415.cms">Jio is slowing down in the race to 500 million subscribers – a goal set by none other than Mukesh Ambani</a> <a href="https://www.businessinsider.in/business/startups/news/nobroker-is-the-38th-indian-startup-to-be-valued-over-a-1-billion-in-2021/articleshow/87867289.cms">NoBroker is the 38th Indian startup to be valued over a billion dollars this year</a> <a href="https://www.businessinsider.in/business/telecom/news/vodafone-idea-hikes-tariffs-by-up-to-500-for-its-popular-plans/articleshow/87864183.cms">Vodafone Idea hikes tariffs by up to ₹500 for its popular plans</a>

If you missed Tarson Products’ IPO allotment, here’s what you should know

<ul><li>Speciality chemicals firm <keyword id="6926409" type="General" weightage="20" keywordseo="ami-organics" source="Orion">Ami Organics</keyword> receives strong response from investors on the second day of IPO bidding as well.</li><li>Overall, <keyword id="11958218" type="General" weightage="20" keywordseo="ami-organics-ipo" source="Orion">Ami Organics IPO</keyword> was oversubscribed 3.90 times on Thursday.</li><li>The grey market is indicating a strong premium of over ₹150.</li></ul>Ami Organics IPO continues receiving strong demand from institutional players and <keyword id="6416579" type="General" weightage="20" keywordseo="retail-investors" source="Orion">retail investors</keyword> on the second day of its initial public offering (IPO). The portion reserved for institutional players was subscribed 1.42 times and that of retail investors was subscribed 6.35 times on September 2. Overall, the IPO was oversubscribed 1.90 times. The IPO received bids for 1.24 crore equity shares as against the issue size of 65.36 lakh equity shares. Overall, the IPO was oversubscribed 3.90 times. The IPO received bids for 2.55 crore equity shares as against the issue size of 65.36 lakh equity shares. Enthusiasm around this IPO is also because of the fact that the grey market indicated over ₹150% premium on the issue price. In the last few months, three specialty chemicals companies -- Clean Science and Technology, Tatva Chintan Pharma Chem and Chemplast Sanmar had hit the market. Except for Chemplast Sanmar, the other two made a strong listing on the exchanges. Ami Organics IPO opened for subscription on September 1 and will close on September 3. It has set a price band of ₹603 to ₹610. Here are some of the important details of the Ami Organics IPO: <table style="border-width: initial; border-style: none;" class="redcator-table-advance"></colgroup><tbody><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Issue details </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;"> </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Price band </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹603 to ₹610 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO open date </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 1 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO close date </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 3 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Allotment date </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 8 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Initiation of refunds </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 9 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Credit of shares to demat account </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 13 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO listing date </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 14 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Minimum lot </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">24 </td></tr></tbody><tbody></tbody><tbody></tbody><tbody></tbody><tbody></tbody></table>Overall, the company is aiming to raise ₹570 crore on the upper price band of ₹603 to ₹610 per share. Ami Organics is a research and development driven manufacturer of speciality chemicals. Analyst Yash Gupta, equity research analyst at Angel Broking, feels the valuations are very expensive, thereby assigning a ‘neutral’ recommendation to the Ami Organics IPO. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/vijaya-diagnostic-ipo-gets-weak-response-from-investors/articleshow/85833700.cms">Vijaya Diagnostic IPO sees tepid response on the second day of bidding</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/startups/news/six-month-old-investment-advisory-startup-dezerv-raises-7-million/articleshow/85865111.cms">Six-month-old investment advisory startup Dezerv raises $7 million</a>

Ami Organics IPO oversubscribed 3.90 times by institutional and retail investors on the second day of bidding

<ul><li><keyword id="11263285" type="UNKNOWN" weightage="20" keywordseo="devyani-international-ipo">Devyani International IPO</keyword> opens on August 4 and closes on August 6.</li><li>Demat account, trading application and UPI ID are mandatory if you are applying for an initial public offering (IPO).</li><li>KFC and Pizza Hut operator <keyword id="142256" type="COMPANY" weightage="20" keywordseo="Devyani-International">Devyani International</keyword> is looking to raise over ₹1,400 crore crore through the public issue.</li></ul>Amid this initial public offering (IPO) season, how to fill IPOs have been one of the most asked questions. So let’s get into the alternatives to apply for an IPO easily. Devyani International is the upcoming IPO that will open on August 4. It is the largest franchisee of Yum Brands in India, which operates quick service restaurant (QSR) brands such as Pizza Hut and KFC, besides its own brands. To invest in these IPOs, you need to apply to buy a ‘lot of shares’ from the market. The bidding for these IPOs is usually open for three days particularly during market hours. For Devyani International IPO the bidding will open on August 4 and close on August 6. A Demat account, a trading application like Zerodha, Angel Broking etc and UPI ID on BHIM app are necessary if you want to invest conveniently in an IPO. Unified payment interface (UPI) is a banking system for money transfers on payment apps like Google Pay, PhonePe and so on. One of the simplest ways to track IPOs and invest in them is through trading platforms. Here’s how you can do it through Zerodha’s Kite application, which is meant for trading stocks and commodities. <ul><li>Login to the mobile app and select the IPO option under the console. If you’re logging in through desktop, then go to console -- portfolio -- IPO.</li><li>You will find a list of IPOs that are open for investment. Select the IPO you want to invest in.</li><li>Enter your UPI ID from the BHIM app. Ensure your UPI ID is mapped to your personal bank account.</li><li>Enter the lot size (number of shares required to buy in one lot) announced by the company.</li><li>Tick on the cut off price for more chances of allotment of shares as it indicates investor’s willingness to subscribe to shares at any price discovered within the price band. Cut off price is the issue price.</li><li>Retail investors can bid for a maximum of three lots.</li><li>After this step, click on the check box to confirm and submit.</li><li>The last step is to accept the mandate request for proceeding with IPO on your BHIM UPI app. Once you accept the mandate, the amount of funds for IPO will be blocked till the allotment.</li><li>Now wait till the allotment date of shares to see if you have received the lot size you bid for.</li></ul>If you have invested through broking firm like Upstox, here are the 5 simple steps to invest in an IPO: Step 1: Login to the Upstox application or website with your credentials. Step 2: Select the IPO that you want to invest in and create an IPO application. Step 3: Add up to 3 bids within the price range. Step 4: Confirm your application. Step 5: Accept the UPI mandate and block funds on your mobile UPI app Another way to invest is through your bank. This option is generally available between 5 a.m. and 11 a.m. on the bank’s website. Here’s how to do it: <ul><li>Log in to your bank’s net banking account.</li><li>Go to the investment section and select the IPO option.</li><li>Fill your investment and bank account details to complete the verification process.</li><li>Later select the IPO you want to apply for.</li><li>Enter the number of shares and bid price.</li><li>Read and accept ‘terms and conditions’ documents.</li><li>Submit your application.</li></ul>SEE ALSO: <a href="https://www.businessinsider.in/business/telecom/news/as-vodafone-idea-shares-dive-10-and-more-heres-a-look-at-what-analysts-had-to-say-about-it-prospect-in-recent-weeks/articleshow/84999673.cms">As Vodafone Idea shares dive 10% and more, here's a look at what analysts had to say about it prospect in recent weeks </a><a href="https://www.businessinsider.in/stock-market/news/devyani-international-exxaro-tiles-krsnaa-diagnostics-and-windlas-biotech-ipos-are-opening-tomorrow/articleshow/85000565.cms">Devyani International, Exxaro Tiles, Krsnaa diagnostics, Windlas biotech IPOs are opening tomorrow</a><a href="https://www.businessinsider.in/stock-market/news/devyani-international-exxaro-tiles-krsnaa-diagnostics-and-windlas-biotech-ipos-are-opening-tomorrow/articleshow/85000565.cms"></a>

Devyani International IPO: Here’s how to apply via banks and apps like Zerodha, Upstox

<keyword id="8763838" type="UNKNOWN" weightage="20" keywordseo="covid-19">Covid-19</keyword> cases among <keyword id="6354458" type="UNKNOWN" weightage="20" keywordseo="US">US</keyword> children are climbing at an alarming rate, with nearly 94,000 diagnosed with the virus last week and trends showing a "continuing substantial increase". Children now account for 15 per cent of Covid-19 cases in the US, according to a study released by The <keyword id="150269" type="ORGANIZATION" weightage="20" keywordseo="American-Academy-of-Pediatrics">American Academy of Pediatrics</keyword> (AAP). The same set of numbers also appear to show that severe illness, hospitalization and death are rare in children who get sick with the coronavirus. In states where data was available, less than 2 per cent of all child Covid-19 cases required hospitalisation. In states reporting, only 0.00-0.03 per cent of all child Covid-19 cases resulted in death, according to AAP. As of August 5, nearly 4.3 million children have <keyword id="184474" type="PERSON" weightage="20" keywordseo="tested-positive">tested positive</keyword> for Covid-19 since the onset of the pandemic. Child cases have steadily increased since the beginning of July, says the AAP report. At this time, nearly 60 per cent of US kids over 12 years have been fully vaccinated and nearly 70 per cent have got at least one shot. Shots for kids under 12 years have not yet been authorised. Pfizer received emergency use authorization for vaccinating those 12 years of age and older; the Moderna and Janssen vaccines are authorised for people 18 years of age and older. Pfizer is expected to apply for emergency approval of its under -12 years shot by October this year. Meanwhile, schools have already started reopening for the Fall term. The latest data from the <keyword id="116293" type="ORGANIZATION" weightage="20" keywordseo="Centers-for-Disease-Control-and-Prevention">Centers For Disease Control and Prevention</keyword> are showing a remarkable shift in caseloads. The 5-11 year olds and 11-15 year olds now account for more cases per 100,000 population than do age group cohorts over 50 years. <keyword id="190126" type="ORGANIZATION" weightage="20" keywordseo="National-Institutes-of-Health">National Institutes of Health</keyword> Director Dr. Francis Collins said on Sunday that the highest number of children -- 1,450 -- were currently hospitalized with Covid-19 since the start of the pandemic. Fears are spiralling that states without tough mask mandates will likely be slammed once again by rising Covid-19 cases as students return to the classroom. The <keyword id="6379474" type="ORGANIZATION" weightage="20" keywordseo="cdc">CDC</keyword> recommends universal indoor masking by all students (age 2 and older), staff, teachers, and visitors to K-12 schools, regardless of vaccination status. Many state governors are defying the mandate even as their ICU corridors are overrun. US President Joe Biden said on Tuesday that he was "very concerned" about case trends among school children. He noted that most of the children getting sick are living in states with low vaccination rates. "So, my plea is that for those who are not vaccinated, think about it." As on August 10, 51 per cent of the US population is fully vaccinated. More than 71 per cent of US adults have got at least one shot. The <keyword id="6356037" type="ORGANIZATION" weightage="20" keywordseo="white-house">White House</keyword> is calling the latest wave a "pandemic of the unvaccinated" and pleading with holdouts to get their shots. The first case of Covid-19 in the US was reported on January 21, 2020. On August 10, the country reported 184,346 new confirmed cases. The virus is blamed for more than 618,000 deaths in the US alone, which accounts for the world's highest caseload and deaths since the start of the pandemic. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/krsnaa-diagnostics-ipo-open-today-check-out-how-to-apply/articleshow/85017014.cms">Krsnaa Diagnostics IPO opens—here is all you need to know</a> <a href="https://www.businessinsider.in/business/startups/news/these-are-some-of-the-highest-paid-founders-of-indian-startups-tapping-capital-markets-this-year/slidelist/85005261.cms">These are some of the highest paid founders of Indian startups tapping capital markets this year</a>

You Searched For "krsnaa diagnostics ipo allotment status" and got 13 results

Krsnaa Diagnostics IPO: How to check your allotment status

Kritti Bhalla

Vijaya Diagnostic IPO’s last day to subscribe, grey market indicates ₹15-₹20 premium

Bhakti Makwana

Here’s how to check Vijaya Diagnostic IPO allotment status, listing date and more

Bhakti Makwana

Krsnaa Diagnostics IPO opens—here is all you need to know

Bhakti Makwana

Watch out for 4 IPOs opening on August 4— here’s a snapshot for each of the companies selling shares tomorrow

Bhakti Makwana

Tarsons Products IPO — today is the last day to subscribe, GMP at ₹180

Kritti Bhalla

Tarsons Products IPO: Here’s how you can check the allotment status

Bhakti Makwana

Tarsons Products IPO listing tomorrow; GMP staggers around ₹170

Bhakti Makwana

Chemplast Sanmar IPO opens today: Check issue price, allotment dates and key details here

Bhakti Makwana

If you missed Tarson Products’ IPO allotment, here’s what you should know

Kritti Bhalla

Ami Organics IPO oversubscribed 3.90 times by institutional and retail investors on the second day of bidding

Bhakti Makwana

Devyani International IPO: Here’s how to apply via banks and apps like Zerodha, Upstox

Bhakti Makwana

Nearly 94,000 kids in the US have tested positive for COVID-19 last week as schools reopen

IANS

Popular Keywords

Buying Guides